Your European Platform to Forge Strategic Partnerships that Transform Real World Evidence
As the industry moves toward evidence-driven product value, pharmaceutical and biotech companies are seeking strategic partners who can unlock the full potential of Real-World Data (RWD) and accelerate Real-World Evidence (RWE)-enabled decision-making. From improving RWD quality and analytics to strengthening launch readiness and post-marketing commitments, organisations are actively investing in data sources, advanced analytics, and strategic services to meet growing HTA and payer expectations.
The Real-World Evidence Summit Europe is the only platform dedicated to the future of RWE-powered drug development offering partners a prime opportunity to showcase solutions that improve data access, enhance analytical rigor, and turn evidence generation into measurable patient and commercial impact.
What to Expect?
Demonstrate Your RWE Capabilities Where they Matter Most
The industry is seeking data providers, analytics innovators, and consultancy expertise to help shape product strategy across development, access, and lifecycle management. Partnering allows you to show exactly how your offerings elevate data integrity, scientific insights, and value demonstration.
Align your brand with the accelerating RWE movement
With new regulatory frameworks like the European Health Data Space driving expanded data access and payer requirements, the industry is seeking scalable and compliant RWE solutions. Position your organisation at the forefront of this shift, as a key enabler of patient- and value-led innovation.
Meet the Decision-Makers Advancing RWE Adoption
This summit unites RWE, Medical Affairs, Market Access, Evidence Generation, and Commercial leaders who are actively selecting partners to improve evidence generation. Build relationships with stakeholders who influence budget, technology adoption, and long-term RWE strategy.
Convert conversations into high-value collaborations
This meeting goes beyond networking, it’s designed to foster strategic partnerships with companies ready to invest in best-in-class RWD sources, AI / ML analytics, and consultancy support to reduce uncertainty in development and market access decisions.
Key Interest Areas
RWE Data Providers
- Access to high-quality patient datasets including EHR, claims, registries, PROs, digital biomarkers
- Capabilities leveraging AI & NLP to unlock insights from unstructured clinical data
- Patient cohort access and population-specific data (rare disease, oncology, chronic conditions)
RWD Analytics Platforms
- AI/ML and advanced analytics for causal inference, modeling, and predictive insights
- Tools enabling federated data access, harmonisation, and real-time analysis platforms supporting HTA-ready evidence generation and regulatory compliance
RWE Consultancy & Strategy Partners
- Expertise in designing RWE studies from pre-clinical through post-launch lifecycle
- HEOR and payer evidence strategies to support reimbursement and reduce uncertainty
- Advisory services to optimise data strategy and operationalise RWE across organisations
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Katie Orchard
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.